Follow
Eizabeth K M Johnstone
Eizabeth K M Johnstone
Harry Perkins Institute of Medical Research and University of Western Australia
Verified email at uwa.edu.au
Title
Cited by
Cited by
Year
Application of BRET to monitor ligand binding to GPCRs
LA Stoddart, EKM Johnstone, AJ Wheal, J Goulding, MB Robers, ...
Nature methods 12 (7), 661-663, 2015
2412015
NanoBRET: the bright future of proximity-based assays
NC Dale, EKM Johnstone, CW White, KDG Pfleger
Frontiers in bioengineering and biotechnology 7, 56, 2019
1452019
Honeybee venom and melittin suppress growth factor receptor activation in HER2-enriched and triple-negative breast cancer
C Duffy, A Sorolla, E Wang, E Golden, E Woodward, K Davern, D Ho, ...
NPJ precision oncology 4 (1), 24, 2020
1062020
Transactivation of RAGE mediates angiotensin-induced inflammation and atherogenesis
RJ Pickering, C Tikellis, CJ Rosado, D Tsorotes, A Dimitropoulos, M Smith, ...
The Journal of clinical investigation 129 (1), 406-421, 2019
742019
Using nanoBRET and CRISPR/Cas9 to monitor proximity to a genome-edited protein in real-time
CW White, HK Vanyai, HB See, EKM Johnstone, KDG Pfleger
Scientific Reports 7 (1), 3187, 2017
592017
Functional interaction between angiotensin II receptor type 1 and chemokine (CC motif) receptor 2 with implications for chronic kidney disease
MA Ayoub, Y Zhang, RS Kelly, HB See, EKM Johnstone, EA McCall, ...
PLoS One 10 (3), e0119803, 2015
492015
AT1R-AT2R-RXFP1 functional crosstalk in myofibroblasts: impact on the therapeutic targeting of renal and cardiac fibrosis
BSM Chow, M Kocan, M Shen, Y Wang, L Han, JY Chew, C Wang, ...
Journal of the American Society of Nephrology 30 (11), 2191-2207, 2019
382019
NanoBRET ligand binding at a GPCR under endogenous promotion facilitated by CRISPR/Cas9 genome editing
CW White, EKM Johnstone, HB See, KDG Pfleger
Cellular signalling 54, 27-34, 2019
382019
Receptor-Heteromer Investigation Technology and its application using BRET
K Pfleger, EK Johnstone
Frontiers in endocrinology 3, 28805, 2012
222012
The oncogene AAMDC links PI3K-AKT-mTOR signaling with metabolic reprograming in estrogen receptor-positive breast cancer
E Golden, R Rashwan, EA Woodward, A Sgro, E Wang, A Sorolla, ...
Nature Communications 12 (1), 1920, 2021
212021
BRET-based assay to monitor EGFR transactivation by the AT1R reveals Gq/11 protein-independent activation and AT1R-EGFR complexes
SL O'Brien, EKM Johnstone, D Devost, J Conroy, ME Reichelt, ...
Biochemical pharmacology 158, 232-242, 2018
212018
Orexin signaling: a complex, multifaceted process
NC Dale, D Hoyer, LH Jacobson, KDG Pfleger, EKM Johnstone
Frontiers in Cellular Neuroscience 16, 812359, 2022
202022
GPCR heteromers: an overview of their classification, function and physiological relevance
NC Dale, EKM Johnstone, KDG Pfleger
Frontiers in Endocrinology 13, 931573, 2022
112022
Investigation of receptor heteromers using NanoBRET ligand binding
EKM Johnstone, HB See, RS Abhayawardana, A Song, KJ Rosengren, ...
International Journal of Molecular Sciences 22 (3), 1082, 2021
92021
Honeybee venom and melittin suppress growth factor receptor activation in HER2-enriched and triple-negative breast cancer. NPJ Precis Oncol 4: 24
C Duffy, A Sorolla, E Wang, E Golden, E Woodward, K Davern, D Ho, ...
92020
Bioluminescence resonance energy transfer approaches to discover bias in GPCR signaling
EKM Johnstone, KDG Pfleger
G Protein-Coupled Receptors in Drug Discovery: Methods and Protocols, 191-204, 2015
52015
Insights into the interaction of LVV-Hemorphin-7 with angiotensin II type 1 receptor
A Ali, EKM Johnstone, B Baby, HB See, A Song, KJ Rosengren, ...
International journal of molecular sciences 22 (1), 209, 2020
42020
Novel pharmacology following heteromerization of the angiotensin II type 2 receptor and the bradykinin type 2 receptor
EKM Johnstone, MA Ayoub, RJ Hertzman, HB See, RM Seeber
Frontiers in Endocrinology 13, 848816, 2022
22022
Complex interactions between the angiotensin II type 1 receptor, the epidermal growth factor receptor and TRIO-dependent signaling partners
EKM Johnstone, RS Abhayawardana, HB See, RM Seeber, SL O'Brien, ...
Biochemical Pharmacology 188, 114521, 2021
22021
Bioluminescence Resonance Energy Transfer (BRET) Technologies to Study GPCRs
NC Dale, CW White, EKM Johnstone, KDG Pfleger
GPCRs as Therapeutic Targets 2, 841-873, 2022
12022
The system can't perform the operation now. Try again later.
Articles 1–20